(3beta,5alpha,9beta,16alpha)-16-Hydroxy-14-methyl-3-(methylamino)-4-methylene-9,19-cyclopregnan-20-one(CAS: 4236-73-1)

The compound (3beta,5alpha,9beta,16alpha)-16-Hydroxy-14-methyl-3-(methylamino)-4-methylene-9,19-cyclopregnan-20-one (CAS: 4236-73-1) is a crystalline solid with a high molecular weight. It exhibits low solubility in water but is more soluble in organic solvents. The compound is chemically stable under normal conditions but can degrade under acidic or basic conditions. It is not reactive towards common reagents and is not prone to hydrolysis or oxidation.

(3beta,5alpha,9beta,16alpha)-16-Hydroxy-14-methyl-3-(methylamino)-4-methylene-9,19-cyclopregnan-20-one (CAS: 4236-73-1) is typically synthesized via a multi-step process involving methylation, hydroxylation, and ring-opening reactions. Key steps include the use of methylating agents and enzymatic reactions. High purity and selectivity are achieved through careful control of reaction conditions and purification techniques.

(3beta,5alpha,9beta,16alpha)-16-Hydroxy-14-methyl-3-(methylamino)-4-methylene-9,19-cyclopregnan-20-one (CAS: 4236-73-1) is primarily used in the pharmaceutical industry for its potential as a progestin. It may also find applications in the sensor industry due to its hormonal properties and could be used in the development of new materials and biomedical applications.

When handling (3beta,5alpha,9beta,16alpha)-16-Hydroxy-14-methyl-3-(methylamino)-4-methylene-9,19-cyclopregnan-20-one (CAS: 4236-73-1), it is essential to use personal protective equipment (PPE) such as gloves, goggles, and lab coats. Work should be conducted in a fume hood to minimize exposure. Spills should be handled carefully with appropriate absorbent materials. The material safety data sheet (MSDS) or safety data sheet (SDS) should be consulted for detailed safety guidelines and emergency procedures.